Meeder Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-162
| Closed | -$10K | – | 2205 |
|
|
2022
Q3 | $10K | Sell |
162
-75
| -32% | -$4.63K | ﹤0.01% | 1340 |
|
|
2022
Q2 | $19K | Sell |
237
-206
| -47% | -$16.5K | ﹤0.01% | 1163 |
|
|
2022
Q1 | $47K | Sell |
443
-20,208
| -98% | -$2.14M | ﹤0.01% | 991 |
|
|
2021
Q4 | $2.23M | Sell |
20,651
-2,659
| -11% | -$286K | 0.22% | 77 |
|
|
2021
Q3 | $2.55M | Buy |
23,310
+1,060
| +5% | +$116K | 0.13% | 137 |
|
|
2021
Q2 | $2.08M | Buy |
22,250
+36
| +0.2% | +$3.37K | 0.1% | 167 |
|
|
2021
Q1 | $2.04M | Buy |
22,214
+22,103
| +19,913% | +$2.03M | 0.1% | 166 |
|
|
2020
Q4 | $8K | Sell |
111
-24,149
| -100% | -$1.74M | ﹤0.01% | 1083 |
|
|
2020
Q3 | $1.88M | Buy |
24,260
+15,214
| +168% | +$1.18M | 0.12% | 142 |
|
|
2020
Q2 | $503K | Buy |
9,046
+30
| +0.3% | +$1.67K | 0.03% | 361 |
|
|
2020
Q1 | $266K | Buy |
9,016
+1,860
| +26% | +$54.9K | 0.02% | 496 |
|
|
2019
Q4 | $259K | Sell |
7,156
-2,054
| -22% | -$74.3K | 0.02% | 538 |
|
|
2019
Q3 | $250K | Sell |
9,210
-13,782
| -60% | -$374K | 0.02% | 553 |
|
|
2019
Q2 | $553K | Buy |
22,992
+5,649
| +33% | +$136K | 0.04% | 395 |
|
|
2019
Q1 | $458K | Buy |
17,343
+7,396
| +74% | +$195K | 0.04% | 388 |
|
|
2018
Q4 | $194K | Buy |
9,947
+8,588
| +632% | +$167K | 0.02% | 504 |
|
|
2018
Q3 | $27K | Buy |
1,359
+914
| +205% | +$18.2K | ﹤0.01% | 955 |
|
|
2018
Q2 | $7.37K | Sell |
445
-196
| -31% | -$3.25K | ﹤0.01% | 1180 |
|
|
2018
Q1 | $9K | Buy |
641
+141
| +28% | +$1.98K | ﹤0.01% | 1110 |
|
|
2017
Q4 | $7K | Buy |
500
+320
| +178% | +$4.48K | ﹤0.01% | 1245 |
|
|
2017
Q3 | $2K | Sell |
180
-1,093
| -86% | -$12.1K | ﹤0.01% | 1513 |
|
|
2017
Q2 | $15K | Buy |
1,273
+820
| +181% | +$9.66K | ﹤0.01% | 896 |
|
|
2017
Q1 | $7K | Buy |
+453
| New | +$7K | ﹤0.01% | 982 |
|